IMP3 and endometrium neoplasm: Other studies evaluating IMP3 in endometrial tumors have reported no expression in benign tissues from their respective control groups.(22-24,34,35) Furthermore, our results support the role of IMP3 in differentiating between malignant and benign lesions.